Bio-Matrix Scientific Group Inc. (BMSN.OB) Secures Partnership to Address Canine Cancer; Ultimate Plans for Human Treatment
Bio-Matrix Scientific Group Inc., a biotech research and development company, recently made a joint announcement with its subsidiary Entest BioMedical Inc. (ENTB.OB), a testing center for various diseases, that they have reached a definitive agreement with Therinject LLC for the development of a immune-therapeutic cancer vaccine. The companies will first focus on the veterinary market, treating animals with tumors. It’s a market that Bio-Matrix chairman and CEO David Koos says is a significant one. The company anticipates treating thousands of animals, generating millions in revenues. “Cancer is the No. 1 cause of death among dogs. It’s estimated that one out…